SCHEMBL5748133

SCHEMBL5748133

Cc1cc(-c2ccc3c4c(cccc24)COC3)nc(N)n1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
▸ HSP90AA1 P07900 18/20 1.00
▸ HSP90AB1 P08238 2/20 0.47
▸ HTR1B P28222 1/20 0.37
▸ HTR2B P41595 1/20 0.37
▸ GPR65 Q8IYL9 1/20 0.37
▸ PIK3CD O00329 1/20 0.37
▸ PIK3CA P42336 1/20 0.37
▸ PIK3CG P48736 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5748568 0.88 HSP90AA1 (0.79) HSP90AA1HSP90AB1HTR1BHTR2BGPR65
SCHEMBL5747376 0.78 HSP90AA1 (0.64) HSP90AA1HSP90AB1HTR1BHTR2BGPR65
SCHEMBL5748563 0.76 HSP90AA1 (0.61) HSP90AA1HSP90AB1HTR1BHTR2BGPR65
SCHEMBL5748130 0.76 HSP90AA1 (0.61) HSP90AA1HSP90AB1HTR1BHTR2BGPR65
SCHEMBL5746670 0.73 HSP90AA1 (0.60) HSP90AA1HSP90AB1HTR1BHTR2BGPR65
SCHEMBL5749014 0.73 HSP90AA1 (0.58) HSP90AA1HSP90AB1HTR1BHTR2BGPR65
SCHEMBL8329880 0.72 HSP90AA1 (0.59) HSP90AA1HSP90AB1HTR1BHTR2BGPR65
Hydrochloric Acid SCHEMBL5751781 0.72 HSP90AA1 (0.59) HSP90AA1HSP90AB1HTR1BHTR2BGPR65
SCHEMBL7077167 0.72 HSP90AA1 (0.56) HSP90AA1HSP90AB1HTR1BHTR2BGPR65
SCHEMBL5748362 0.72 HTR1B (0.61) HSP90AA1HSP90AB1HTR1BHTR2BGPR65

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0901474-B1 ARYL PYRIMIDINE DERIVATIVES HOFFMANN LA ROCHE (CH) 2006-04-19 — — EP disclosed
EP-1321169-A1 Combination of a serotonin receptor antagonist with a histidine decarboxylase inhibitor as a medicament Biofrontera Pharmaceuticals AG (DE) 2003-06-25 — — EP disclosed
Send feedback